Press release
Methylmalonic Acidemia Market is Expected to Show a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies- LogicBio Therapeutics, Inc, ModernaTX, Inc.
Download Sample Report to know more @https://www.delveinsight.com/sample-request/methylmalonic-acidemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Methylmalonic Acidemia Overview
Methylmalonic Acidemia is an autosomal recessive disorder of amino acid metabolism, involving a defect in the conversion of methyl malonyl-coenzyme A (CoA) to succinyl-CoA. Patients typically present at the age of 1 month to 1 year with neurologic manifestations, such as seizure, encephalopathy, and stroke.
Methylmalonic acidemia stems from several genotypes all forms of the disorder usually diagnosed in the early neonatal period, presenting progressive encephalopathy, and secondary hyperammonemia. The disorder can result in death if undiagnosed or left untreated. It is estimated that this disorder has a frequency of 1 in 48,000 births, though the high mortality rate in diagnosed cases makes exact determination difficult. Methylmalonic acidemias are found with an equal frequency across ethnic boundaries.
Click here to learn more about the Methylmalonic Acidemia Market Landscape @https://www.delveinsight.com/sample-request/methylmalonic-acidemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Key Highlights from Methylmalonic Acidemia Market Report
Key Companies working in Methylamalonic Acidmia include
LogicBio Therapeutics
ModernaTX, Inc.
and many others
Key Therapies included in the Methylmalonic Acidima market includes
hLB-001
mRNA-3705
and many others.
Methylmalonic AcidemiaTreatment Market
Treatment for all forms of this condition primarily relies on a low-protein diet, and depending on what variant of the disorder the individual suffers from, various dietary supplements. All variants respond to the levo isomer of carnitine as the improper breakdown of the affected substances results in sufferers developing a carnitine deficiency. The carnitine also assists in the removal of acyl-CoA, the buildup of which is common in low-protein diets by converting it into acyl-carnitine which can be excreted in the urine. Some forms of methylmalonyl acidemia are responsive to cobalamin although cyanocobalamin supplements could prove detrimental to some forms. If the individual proves responsive to both cobalamin and carnitine supplements, then it may be possible for them to ingest substances that include small amounts of the problematic amino acids isoleucine, threonine, methionine, and valine without causing an attack.
Learn more about the treatment market for Methylmalonic Acidemia @ https://www.delveinsight.com/report-store/methylmalonic-acidemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
The Report Covers the Methylmalonic Acidemia Epidemiology Segmented by:
Methylmalonic Acidemia prevalent cases
Methylmalonic Acidemia Incident Cases
Methylmalonic Acidemia treatment cases
Methylmalonic Acidemia diagnosed cases
Methylmalonic Acidemia Dug Profile and Companies Covered
Moderna Tx- mRNA-3705
Logic Bio Therapeutics- hLB-001
HemoShear Therapeutics- mRNA-3705
And many others.
Learn more about the Key Companies and Emerging Therapies in the Methylmalonic Acidemia Market @https://www.delveinsight.com/report-store/methylmalonic-acidemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Table of Contents
Key Insights
Methylmalonic Acidemia Introduction
Executive Summary of Methylmalonic Acidemia
Disease Background and Overview
Methylmalonic Acidemia Epidemiology and patient population
Methylmalonic Acidemia Emerging Therapies
Methylmalonic Acidemia Market Outlook
Methylmalonic Acidemia Market Access and Reimbursement of Therapies
Methylmalonic Acidemia Market Drivers
Methylmalonic Acidemia Market Barriers
Appendix
Methylmalonic Acidemia Report Methodology
DelveInsight Capabilities
Disclaimer
Learn about the detailed offerings of the Methylmalonic Acidemia Market Outlook report @ https://www.delveinsight.com/report-store/methylmalonic-acidemia-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Related Reports
Methylmalonic Acidemia Epidemiology Forecast
https://www.delveinsight.com/report-store/methylmalonic-acidemia-epidemiology-forecast?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Methylmalonic Acidemia Pipeline Forecast
https://www.delveinsight.com/report-store/methylmalonic-acidemia-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=dpr
Trending reports by DelveInsight
Functional Constipation Market
https://www.delveinsight.com/report-store/chronic-constipation-market
Lebers Hereditary Optic Neuropathy Lhon Market https://www.delveinsight.com/report-store/lebers-hereditary-optic-neuropathy-lhon-market
Gastric Neuroendocrine Tumors Market
https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market
Immune Thrombocytopenic Purpura Market
https://www.delveinsight.com/report-store/immune-thrombocytopenia-itp-market
Visceral Pain Associated With GI Disorders Market
https://www.delveinsight.com/report-store/visceral-pain-associated-with-gi-disorders-market
Bullous Pemphigoid Market
https://www.delveinsight.com/report-store/bullous-pemphigoid-market
Cyclin-dependent Kinase-like 5 Deficiency Disorder Market https://www.delveinsight.com/infographics/cyclin-dependent-kinase-like-5-cdkl5-deficiency-disorder-market
Myocarditis Market
https://www.delveinsight.com/report-store/myocarditis-market
Recurrent Blood Clots Market
https://www.delveinsight.com/report-store/recurrent-blood-clots-thrombophilia-market
Zollinger-ellison Syndrome Market
https://www.delveinsight.com/report-store/zollinger-ellison-syndrome-market
Age-related Hearing Loss Medical Device Market
https://www.delveinsight.com/blog/age-related-hearing-loss-device-market
Heart Sounds Sensors Market
https://www.delveinsight.com/report-store/heart-sounds-sensors-electronic-stethoscope-market
Hypoplastic Left Heart Syndrome Hlhs Market
https://www.delveinsight.com/report-store/hypoplastic-left-heart-syndrome-market
Infectious Arthritis/Septic Arthritis Market
https://www.delveinsight.com/report-store/infectious-arthritisseptic-arthritis-market
Plasmacytoma Market
https://www.delveinsight.com/report-store/plasmacytoma-market
Agoraphobia Market
https://www.delveinsight.com/report-store/agoraphobia-market
Clinically Isolated Syndrome CIS Market
https://www.delveinsight.com/report-store/clinically-isolated-syndrome-cis-market
Fucosidosis Market
https://www.delveinsight.com/report-store/fucosidosis-market
Major Depressive Disorder Market
https://www.delveinsight.com/report-store/major-depressive-disorder-market
Neuronal Ceroid-lipofuscinoses Market
https://www.delveinsight.com/report-store/neuronal-ceroid-lipofuscinoses-cln1-disease-market
Orthotic Devices Market
https://www.delveinsight.com/report-store/orthotic-devices-market:
DelveInsight Business Research LLP
Adya Kaul
info@delveinsight.com
https://www.delveinsight.com
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate business growth and overcome challenges with a practical approach.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Methylmalonic Acidemia Market is Expected to Show a Healthy Growth Rate During the Study Period (2019-2032)| Key Companies- LogicBio Therapeutics, Inc, ModernaTX, Inc. here
News-ID: 3156509 • Views: …
More Releases from DelveInsight Business Research LLP
Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…
Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…
Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…
Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Methylmalonic
Methylmalonic Acidemia Market trends, Diagnosis, and Treatment Landscape
Methylmalonic Acidemia (MMA) is a rare inherited metabolic disorder resulting from defects in the metabolism of certain amino acids, cholesterol, and fatty acids. It is typically caused by mutations in genes responsible for the enzyme methylmalonyl-CoA mutase or related pathways. Patients with MMA are unable to properly break down specific compounds, leading to accumulation of toxic substances in the blood, which can result in developmental delays, recurrent metabolic crises, and…
Methylmalonic Acid Market: An In-Depth Analysis
In 2024, the market was valued at approximately USD 250 million and is projected to reach around USD 400 million by 2033, reflecting a compound annual growth rate (CAGR) of 5.5% from 2025 to 2033.
Methylmalonic Acid Market Overview
Methylmalonic acid serves as a crucial biomarker in clinical settings, aiding in the diagnosis of conditions such as methylmalonic acidemia and other vitamin B12-related disorders. The market's growth is fueled by the rising…
Methylmalonic Acidemia (MMA) Market Size Projected To Reach $12.5 Billion By 203 …
The Methylmalonic Acidemia (MMA) Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Methylmalonic Acidemia (MMA) Market?
The market for methylmalonic acidemia (MMA) has experienced robust growth in the past few years. The size of the market is forecasted to…
Methylmalonic Acidemia Market 2023 Trends, Top Industry Players and Future Trend …
"According to the research report, the global methylmalonic acidemia market was valued at USD 9.16 billion in 2022 and is expected to reach USD 14.78 billion by 2032, to grow at a CAGR of 5.0% during the forecast period."
Get Sample with Latest Trends and Future Advancements @ https://www.polarismarketresearch.com/industry-analysis/methylmalonic-acidemia-market/request-for-sample
Polaris Market Research has recently published its latest analysis on Methylmalonic Acidemia Market 2023: By Types, Applications, Size, Share, Key Players & Regions…
Methylmalonic Acid Market Will Generate Record Revenue by 2029
The Methylmalonic Acid Market is anticipated to grow at a significant CAGR during the forecast period. Methylmalonic acid (MMA) is a substance created by the human body when it digests protein. The amount of vitamin B12 in the body controls the production of MMA in the body. A high amount of MMA typically means a deficiency of vitamin B12.?The major factor driving the growth of the market during the forecast…
Methylmalonic Acidemia Market to Show a Rise During the Forecast Period asserts …
DelveInsight's "Methylmalonic Acidemia Market Insights, Epidemiology, and Market Forecast-2032" report delivers an in-depth understanding of Methylmalonic Acidemia, historical and forecasted epidemiology as well as the Methylmalonic Acidemia market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
The Methylmalonic Acidemia market report provides current treatment practices, emerging drugs, Methylmalonic Acidemia market share of the individual therapies, and current and forecasted Methylmalonic Acidemia market size…
